CClinicalTrials.gg
CompletedNCT00987896Updated Oct 1, 2009

Megachannel Device for Advanced Colonoscopy

A Phase 2 interventional study of Colonoscopy with Megachannel™ device loaded in Multiple Polyps Right Colon, Large Polyp Right Colon and Suspected Polyp Right Colon, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-10-01.

Sponsored by Medical University of Vienna · Phase 2, Interventional, and Diagnostic

Phase
Phase 2
Study type
Interventional
Enrollment
41
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Megachannel is a newly developed colonic access system allowing rapid and multiple passes of the colonoscope to the right colon.

The investigators want to conduct a multinational study to evaluate the safety and clinical feasibility of placing a 100 cm Megachannel prototype in the right colon.

Read the detailed description

Patients scheduled for colonoscopy with suspected right colonic polypoid lesions will be included. The prototype will loaded onto a 160 cm lower GI endoscope and introduced via colonoscopic guidance. Time to cecum, total investigation time, clinical feasibility and complications will be recorded.

02

Conditions studied

  • Multiple Polyps Right Colon
  • Large Polyp Right Colon
  • Suspected Polyp Right Colon

Browse trials for

Keywords

  • colonoscopy
  • polypectomy
  • NOTES
03

In context

Polyps

385 studies on the registry are indexed under Polyps; 59 are open to participants now.

This study's enrollment of 41 is below the median of 160 across 250 interventional studies indexed under Polyps.

Browse Polyps studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients scheduled for colonoscopy with suspected large or multiple polys in the right colon

Exclusion criteria

Exclusion Criteria:

  • previous abdominal surgery
  • history or currently diagnosed intra-abdominal cancer
  • patients presenting with unstable angina
  • drug abusers
  • pregnant women
  • patients with known colonic strictures
05

Study design

Phase
Phase 2
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Megachannel Application

    Colonoscopy with loaded Megachannel is performed

    Device: Colonoscopy with Megachannel™ device loaded

Interventions

  • DeviceColonoscopy with Megachannel™ device loaded

    Before colonoscopy, megachannel is loaded on the endoscope, during colonoscopy megachannel will be inserted into the patient via the endoscope placed in the colon

    Also known as: Megachannel(TM), produced by Minos Medical, Irvine, CA

06

What researchers measure

Primary outcomes

  1. Safety and clinical feasibility of performing colonoscopy with megachannel

    Time frame: during every single colonoscopy in the study

07

Study locations

1 site
  • Medical University of Vienna
    Vienna, 1090, Austria
08

References and documents

Publications

  • Silberhumer GR, Birsan T, Noda W, Unger E, Mayr W, Lang S, Prager G, Gasche C. Design and instrumentation of new devices for performing appendectomy at colonoscopy (with video). Gastrointest Endosc. 2008 Jul;68(1):139-45. doi: 10.1016/j.gie.2008.02.024. Epub 2008 May 2. PubMed 18455170 ↗
  • Ferlitsch A, Silberhumer GR, Noda W, Birsan T, Desai D, Kumar A, Rao GV, Khakar A, Gomez NA, Gasche C. A novel endoscopic device for repeated right-side colonic access during colonoscopy (with video). Gastrointest Endosc. 2010 May;71(6):1052-5. doi: 10.1016/j.gie.2009.12.059. PubMed 20438892 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00987896
Lead sponsor
Medical University of Vienna
First posted
Oct 1, 2009
Start date
Nov 2007
Primary completion
Jul 2008
Completion
Oct 2008
Last update
Oct 1, 2009

Study contacts

Arnulf Ferlitsch, MD
principal investigator · Medical University of Vienna

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion